Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review

Atrial fibrillation (AF) is a cardiac arrhythmia caused by electrophysiological anomalies in the atrial tissue, tissue degradation, structural abnormalities, and comorbidities. A direct relationship exists between AF and altered mitochondrial activity resulting from membrane potential loss, contract...

Full description

Bibliographic Details
Main Authors: Antônio da Silva Menezes Júnior, Ana Luísa Guedes de França-e-Silva, Joyce Monteiro de Oliveira, Daniela Melo da Silva
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/1/535
_version_ 1797358663912914944
author Antônio da Silva Menezes Júnior
Ana Luísa Guedes de França-e-Silva
Joyce Monteiro de Oliveira
Daniela Melo da Silva
author_facet Antônio da Silva Menezes Júnior
Ana Luísa Guedes de França-e-Silva
Joyce Monteiro de Oliveira
Daniela Melo da Silva
author_sort Antônio da Silva Menezes Júnior
collection DOAJ
description Atrial fibrillation (AF) is a cardiac arrhythmia caused by electrophysiological anomalies in the atrial tissue, tissue degradation, structural abnormalities, and comorbidities. A direct relationship exists between AF and altered mitochondrial activity resulting from membrane potential loss, contractile dysfunction, or decreased ATP levels. This review aimed to elucidate the role of mitochondrial oxidative mechanisms in AF pathophysiology, the impact of mitochondrial oxidative stress on AF initiation and perpetuation, and current therapies. This review followed the Preferred Reporting Items for Systematic Reviews and the Meta-Analysis Extension for Scoping Reviews. PubMed, Excerpta Medica Database, and Scopus were explored until June 2023 using “MESH terms”. Bibliographic references to relevant papers were also included. Oxidative stress is an imbalance that causes cellular damage from excessive oxidation, resulting in conditions such as AF. An imbalance in reactive oxygen species production and elimination can cause mitochondrial damage, cellular apoptosis, and cardiovascular diseases. Oxidative stress and inflammation are intrinsically linked, and inflammatory pathways are highly correlated with the occurrence of AF. AF is an intricate cardiac condition that requires innovative therapeutic approaches. The involvement of mitochondrial oxidative stress in the pathophysiology of AF introduces novel strategies for clinical treatment.
first_indexed 2024-03-08T15:04:39Z
format Article
id doaj.art-65e0f286ec714272bc34fc332d0a22d5
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-08T15:04:39Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-65e0f286ec714272bc34fc332d0a22d52024-01-10T14:59:52ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-12-0125153510.3390/ijms25010535Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping ReviewAntônio da Silva Menezes Júnior0Ana Luísa Guedes de França-e-Silva1Joyce Monteiro de Oliveira2Daniela Melo da Silva3Internal Medicine Department, Medicine School, Federal University of Goiás, Goiânia 74605-020, GO, BrazilInternal Medicine Department, Medicine School, Federal University of Goiás, Goiânia 74605-020, GO, BrazilMedicine Department, Medical and Life School, Pontifical Catholic University of Goiás, Avenida Universitária, 1440, Sector Universitario, Goiânia 74605-010, GO, BrazilInternal Medicine Department, Medicine School, Federal University of Goiás, Goiânia 74605-020, GO, BrazilAtrial fibrillation (AF) is a cardiac arrhythmia caused by electrophysiological anomalies in the atrial tissue, tissue degradation, structural abnormalities, and comorbidities. A direct relationship exists between AF and altered mitochondrial activity resulting from membrane potential loss, contractile dysfunction, or decreased ATP levels. This review aimed to elucidate the role of mitochondrial oxidative mechanisms in AF pathophysiology, the impact of mitochondrial oxidative stress on AF initiation and perpetuation, and current therapies. This review followed the Preferred Reporting Items for Systematic Reviews and the Meta-Analysis Extension for Scoping Reviews. PubMed, Excerpta Medica Database, and Scopus were explored until June 2023 using “MESH terms”. Bibliographic references to relevant papers were also included. Oxidative stress is an imbalance that causes cellular damage from excessive oxidation, resulting in conditions such as AF. An imbalance in reactive oxygen species production and elimination can cause mitochondrial damage, cellular apoptosis, and cardiovascular diseases. Oxidative stress and inflammation are intrinsically linked, and inflammatory pathways are highly correlated with the occurrence of AF. AF is an intricate cardiac condition that requires innovative therapeutic approaches. The involvement of mitochondrial oxidative stress in the pathophysiology of AF introduces novel strategies for clinical treatment.https://www.mdpi.com/1422-0067/25/1/535oxidative stressatrial fibrillationmitochondrial dysfunctioninflammationantioxidant drug discovery
spellingShingle Antônio da Silva Menezes Júnior
Ana Luísa Guedes de França-e-Silva
Joyce Monteiro de Oliveira
Daniela Melo da Silva
Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review
International Journal of Molecular Sciences
oxidative stress
atrial fibrillation
mitochondrial dysfunction
inflammation
antioxidant drug discovery
title Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review
title_full Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review
title_fullStr Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review
title_full_unstemmed Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review
title_short Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review
title_sort developing pharmacological therapies for atrial fibrillation targeting mitochondrial dysfunction and oxidative stress a scoping review
topic oxidative stress
atrial fibrillation
mitochondrial dysfunction
inflammation
antioxidant drug discovery
url https://www.mdpi.com/1422-0067/25/1/535
work_keys_str_mv AT antoniodasilvamenezesjunior developingpharmacologicaltherapiesforatrialfibrillationtargetingmitochondrialdysfunctionandoxidativestressascopingreview
AT analuisaguedesdefrancaesilva developingpharmacologicaltherapiesforatrialfibrillationtargetingmitochondrialdysfunctionandoxidativestressascopingreview
AT joycemonteirodeoliveira developingpharmacologicaltherapiesforatrialfibrillationtargetingmitochondrialdysfunctionandoxidativestressascopingreview
AT danielamelodasilva developingpharmacologicaltherapiesforatrialfibrillationtargetingmitochondrialdysfunctionandoxidativestressascopingreview